Evaluation of predictive biomarkers for nivolumab in patients (pts) with metastatic clear cell renal cell carcinoma (mccRCC) from the CheckMate-025 (CM-025) trial Meeting Abstract
| Authors: | Ficial, M.; Jegede, O.; Sant'Angelo, M.; Moreno, S.; Braun, D. A.; Wind-Rotolo, M.; Pignon, J. C.; Catalano, P. J.; Sun, M. X. N.; Van Allen, E. M.; Freeman, G. J.; Sharpe, A.; Hodi, F. S.; Motzer, R. J.; Wu, C. J.; Atkins, M. B.; McDermott, D. F.; Shukla, S. A.; Choueiri, T. K.; Signoretti, S. |
| Abstract Title: | Evaluation of predictive biomarkers for nivolumab in patients (pts) with metastatic clear cell renal cell carcinoma (mccRCC) from the CheckMate-025 (CM-025) trial |
| Meeting Title: | 56th Annual Meeting of the American Society of Clinical Oncology (ASCO) |
| Journal Title: | Journal of Clinical Oncology |
| Volume: | 38 |
| Issue: | 15 Suppl. |
| Meeting Dates: | 2020 May 29-31 |
| Meeting Location: | Virtual |
| ISSN: | 0732-183X |
| Publisher: | American Society of Clinical Oncology |
| Date Published: | 2020-05-20 |
| Start Page: | 282s |
| Language: | English |
| ACCESSION: | WOS:000560368302279 |
| PROVIDER: | wos |
| DOI: | 10.1200/JCO.2020.38.15_suppl.5023 |
| Notes: | Meeting Abstract: 5023 -- Source: Wos |
